Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
How GenAI Creates Personalized Medical Content for 10,000 HCPs at Once
For years, pharma companies have understood the importance of personalized communication. The idea is simple: doctors respond better when content reflects their interests, their patients, and their clinical context. Relevance drives engagement, and engagement drives outcomes.
Measuring Omnichannel ROI in Pharma: Metrics That Actually Tell You If It’s Working
Most pharma companies are not underinvesting in omnichannel. They are under-measuring it. The problem is not whether omnichannel activity is happening. The problem is whether anyone can prove what it is changing.
Multiplier AI Unveils Its GenAI-Powered Medical Writing Platform
The pressure on clinical teams to document faster, comply with more regulations, and do more with fewer resources has never been greater. Yet most medical writing processes still rely on manual workflows that were not built for today's pace.
Email vs Rep Visit vs Digital Ads: How AI Decides the Best Channel for Each Doctor
The hidden inefficiency in pharma engagement strategies Most pharma teams do not struggle with a lack of channels. They struggle with choosing the right one at the right time.
What Does True Omnichannel Mean in Pharma? And Why Most Companies Are Still Multichannel
If you ask ten pharma leaders what omnichannel means, you will likely get ten different answers. Some will describe it as using multiple channels. Others will say it is about coordinating campaigns.
HCP Omnichannel Engagement: The 4-Stage Maturity Model for Pharma Teams
Many pharma organizations have already invested heavily in digital tools, CRM systems, and marketing platforms. On paper, it looks like progress has been made. There are more channels, more campaigns, and more data than ever before.
Pharma AI Implementation: A Practical Playbook for Moving From MVP to Scale in 2026
Pharma AI implementation moves through 3 operational phases — MVP, Production, and Scale. Most pharma AI initiatives fail in the transition from MVP to Production, where data fragmentation, system integration, compliance, and ownership gaps surface.
AI Next Best Action for Pharma Sales: Improve Physician Engagement & Productivity
Pharma sales representatives no longer need longer call lists. They need smarter call priorities. AI-driven Next Best Action helps reps decide which physicians to engage, what message to share, when to follow up, and when to pause outreach.
HCP Data Enrichment Using AI and External Healthcare Datasets
Most pharma companies already have doctor data. The real problem is that much of it is incomplete, outdated, or too shallow to support modern targeting, segmentation, and AI-driven engagement. HCP data enrichment solves this by turning basic physician records into deeper physician intelligence.
AI-Powered Call Planning for Pharma Reps: Replacing Gut Feel with Data
If you spend time observing how pharma reps plan their day, a pattern becomes clear very quickly. There is a lot of effort going into planning, but very little of it is actually driven by real data. Most decisions are influenced by habit, familiarity with territory, or past experience rather than current signals.
How to Build a Unified Data Layer for Pharma AI: The Foundation for Real-Time Intelligence in 2026
Most pharma AI initiatives fail before they scale — not because the models are weak, but because the data underneath them is fragmented. Pharma commercial teams across India, the US, and the UK have spent the past few years investing in predictive models
AI Copilots for Pharma Field Teams: How to Augment Reps With Real-Time Intelligence
Pharma has spent the past decade investing heavily in digital transformation — CRMs got more sophisticated, data pipelines improved, analytics platforms expanded, and AI showed up across marketing and operations.